Company Updates
There are 50 results matching your search criteria
Clear all filters
Company Updates
Owlstone Medical Appoints Mark Capone to Board of Directors
Breath Biopsy
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
COVID-19
Owlstone Medical Publishes Data on the Use of Face Mask Filters to Capture Viral Particles for SARS-CoV-2 Detection
Breath Biopsy
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Breath Biopsy
Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
Breath Biopsy
Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD
Company Updates
Owlstone Medical Appoints Neil Tween as Chief Financial Officer
Company Updates
Owlstone Medical named as one of FierceMedTech’s “Fierce 15” companies of 2019
Breath Biopsy
Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure
Breath Biopsy
Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-Invasive Breath Biopsy
Breath Biopsy
Owlstone Medical to Contribute Breath Biopsy to 3TR, the Largest-ever IMI2 Immunology Project to Improve Disease Management Across Seven Immune-Mediated Diseases
